5801 - 5850 of 6171 Results
Title
Year
-
OPENTitle: SIRT2 as a Therapeutic Target for Age-Related DisordersJournal Name: Frontiers in PharmacologyPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3389/fphar.2012.00082Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphar.2012.00082/pdfCitation Count: 129
- The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein Expression2012OPENTitle: The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein ExpressionJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/142372Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/142372.pdfCitation Count: 48
- The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function2012OPENTitle: The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory functionJournal Name: The Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 49Issue #: 8Start Page: 1269End Page: 1269Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2011.06.0103Citation Count: 26
-
OPENTitle: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/564812Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/564812.pdfCitation Count: 4
-
OPENTitle: Regulation of Physiologic Actions of LRRK2: Focus on AutophagyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 10Issue #: 1-4Start Page: 238End Page: 241Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000332599Best OA location URL: https://www.karger.com/Article/Pdf/332599Citation Count: 39
-
OPENTitle: Pathophysiology of manganese-associated neurotoxicityJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 33Issue #: 4Start Page: 881End Page: 886Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.12.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3350837Citation Count: 129
- PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity2011OPENTitle: PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrityJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 8Start Page: 1725End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddr606Best OA location URL: https://academic.oup.com/hmg/article-pdf/21/8/1725/17258592/ddr606.pdfCitation Count: 156
- A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial Complex I activity2011OPENTitle: A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial Complex I activityJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 209Issue #: 1Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20111126Best OA location URL: http://jem.rupress.org/content/jem/209/1/1.full.pdfCitation Count: 37
-
OPENTitle: Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 1Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31823ed101Best OA location URL: https://n.neurology.org/content/neurology/78/1/55.full.pdfCitation Count: 39
-
OPENTitle: Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 230Issue #: 2Start Page: 309End Page: 316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2011.12.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3324279Citation Count: 145
- Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's Disease2011OPENTitle: Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/795294Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/795294.pdfCitation Count: 32
- Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease2011OPENTitle: Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 4Start Page: 560End Page: 568Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22691Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.22691Citation Count: 235
- Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease Neuropathology2011OPENTitle: Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease NeuropathologyJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 4Start Page: 547End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2011.00557.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3639011Citation Count: 144
-
OPENTitle: Sertraline for the Treatment of Depression in Alzheimer Disease: Genetic InfluencesJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 24Issue #: 4Start Page: 222End Page: 228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0891988711422527Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3535452Citation Count: 14
-
OPENTitle: Panels, Mini-Panels and Study GroupsJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 36Issue #: S1Start Page: S1End Page: S74Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2011.290Best OA location URL: https://www.nature.com/articles/npp2011290.pdfCitation Count: 0
- Biochemical and Morphological Characterization of the AβPP/PS/Tau Triple Transgenic Mouse Model and Its Relevance to Sporadic Alzheimer's Disease2011OPENTitle: Biochemical and Morphological Characterization of the AβPP/PS/Tau Triple Transgenic Mouse Model and Its Relevance to Sporadic Alzheimer's DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 27Issue #: 2Start Page: 361End Page: 376Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-110608Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3327160Citation Count: 17
-
OPENTitle: CNTRICS Imaging Biomarkers Final Task Selection: Long-Term Memory and Reinforcement LearningJournal Name: Schizophrenia BulletinPublisher: Oxford University Press (OUP)Vol: 38Issue #: 1Start Page: 62End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/schbul/sbr168Best OA location URL: https://academic.oup.com/schizophreniabulletin/article-pdf/38/1/62/5351297/sbr168.pdfCitation Count: 28
-
OPENTitle: Solvent exposures and parkinson disease risk in twinsJournal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 6Start Page: 776End Page: 784Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22629Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.22629Citation Count: 164
- CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease2011OPENTitle: CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative diseaseJournal Name: Integrative BiologyPublisher: Oxford University Press (OUP)Vol: 3Issue #: 12Start Page: 1188End Page: 1196Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1039/c1ib00018gBest OA location URL: https://europepmc.org/articles/pmc3334303?pdf=renderCitation Count: 83
-
OPENTitle: Membrane proteins in four acts: Function precedes structure determinationJournal Name: MethodsPublisher: Elsevier BVVol: 55Issue #: 4Start Page: 415End Page: 420Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ymeth.2011.11.001Best OA location URL: https://europepmc.org/articles/pmc3282554?pdf=renderCitation Count: 9
-
OPENTitle: Brain biochemistry in autopsied patients with essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 113End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3261329Citation Count: 55
-
OPENTitle: Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 20Start Page: 1801End Page: 1807Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318237f649Best OA location URL: https://n.neurology.org/content/neurology/77/20/1801.full.pdfCitation Count: 56
-
OPENTitle: Quantitative telemedicine ratings in Batten diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 20Start Page: 1808End Page: 1811Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182377e29Citation Count: 27
- Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine Model2011OPENTitle: Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine ModelJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 544End Page: 554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.216Best OA location URL: http://www.cell.com/article/S1525001616305111/pdfCitation Count: 30
-
OPENTitle: A soluble α-synuclein construct forms a dynamic tetramerJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 108Issue #: 43Start Page: 17797End Page: 17802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1113260108Citation Count: 439
-
OPENTitle: Neuroprotective activities of regulatory T cellsJournal Name: Trends in Molecular MedicinePublisher: Elsevier BVVol: 17Issue #: 12Start Page: 687End Page: 688Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molmed.2011.08.005Best OA location URL: http://doi.org/10.1016/j.molmed.2011.08.005Citation Count: 51
- Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulator2011OPENTitle: Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulatorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 21Issue #: 23Start Page: 6955End Page: 6959Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2011.09.131Best OA location URL: https://doi.org/10.7270/q2s75grqCitation Count: 18
- Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI Data2011OPENTitle: Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI DataJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 26Issue #: s3Start Page: 77End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-0006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4587763Citation Count: 50
- Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model2011OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qBest OA location URL: https://doi.org/10.7270/q25q4whdCitation Count: 59
-
OPENTitle: Plasticity in Early Alzheimer DiseaseJournal Name: Topics in Geriatric RehabilitationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 27Issue #: 4Start Page: 257End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/tgr.0b013e31821e588eBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3419487Citation Count: 38
-
OPENTitle: Apathy and Depression: Separate Factors in Parkinson's DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 17Issue #: 6Start Page: 1058End Page: 1066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617711001068Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3302577Citation Count: 130
-
OPENTitle: Subthalamic nucleus stimulation reverses mediofrontal influence over decision thresholdJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 11Start Page: 1462End Page: 1467Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.2925Citation Count: 652
- Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study2011OPENTitle: Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker StudyJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2283End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23934Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3337217Citation Count: 23
- BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response2011OPENTitle: BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein responseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 30Issue #: 21Start Page: 4465End Page: 4478Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/emboj.2011.318Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/emboj.2011.318Citation Count: 112
-
OPENTitle: GFAP mutations, age at onset, and clinical subtypes in Alexander diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 13Start Page: 1287End Page: 1294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182309f72Best OA location URL: https://n.neurology.org/content/neurology/77/13/1287.full.pdfCitation Count: 228
-
OPENTitle: Impaired Economy of Gait and Decreased Six-Minute Walk Distance in Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/241754Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/241754.pdfCitation Count: 36
- Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress2011OPENTitle: Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stressJournal Name: Free Radical Biology and MedicinePublisher: Elsevier BVVol: 51Issue #: 11Start Page: 2007End Page: 2017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.freeradbiomed.2011.08.030Citation Count: 189
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study2011OPENTitle: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 10Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2Best OA location URL: http://www.thelancet.com/article/S1474442211701752/pdfCitation Count: 316
-
OPENTitle: Familial Aggregation of Panic Disturbances in Parkinson's DiseaseJournal Name: Journal of NeuropsychiatryPublisher: American Psychiatric Association PublishingVol: 23Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.23.4.417Best OA location URL: https://europepmc.org/articles/pmc3547673?pdf=renderCitation Count: 1
-
OPENTitle: Translation Initiator EIF4G1 Mutations in Familial Parkinson DiseaseJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 89Issue #: 3Start Page: 398End Page: 406Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2011.08.009Best OA location URL: http://www.cell.com/article/S0002929711003594/pdfCitation Count: 279
-
OPENTitle: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/ncomms1453Best OA location URL: https://www.nature.com/articles/ncomms1453.pdfCitation Count: 445
-
OPENTitle: Network correlates of the cognitive response to levodopa in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 858End Page: 865Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c6224Best OA location URL: https://n.neurology.org/content/neurology/77/9/858.full.pdfCitation Count: 64
- Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging2011OPENTitle: Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imagingJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23917Best OA location URL: http://doi.org/10.1002/mds.23917Citation Count: 176
-
OPENTitle: Neurologist care in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 9Start Page: 851End Page: 857Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31822c9123Best OA location URL: https://n.neurology.org/content/neurology/77/9/851.full.pdfCitation Count: 265
-
OPENTitle: Induction of pluripotent stem cells from autopsy donor-derived somatic cellsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 502Issue #: 3Start Page: 219End Page: 224Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2011.07.048Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3195418Citation Count: 25
- Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor2011OPENTitle: Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factorJournal Name: NeurosciencePublisher: Elsevier BVVol: 194Issue #:Start Page: 220End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2011.07.072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3408714Citation Count: 34
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities2011OPENTitle: Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 412Issue #: 1Start Page: 94End Page: 110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2011.07.033Citation Count: 121
-
OPENTitle: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1408Issue #:Start Page: 88End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2011.06.057Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4120020Citation Count: 74
- Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets2011OPENTitle: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and plateletsJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1812Issue #: 11Start Page: 1508End Page: 1514Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004Best OA location URL: https://doi.org/10.1016/j.bbadis.2011.07.004Citation Count: 61
- Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia2011OPENTitle: Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2339End Page: 2357Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awr165Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2339/13735225/awr165.pdfCitation Count: 131